Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G17DT + Irinotecan in Refractory Metastatic Colorectal Cancer
NCT02118064Phase 2Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Mar 2001
- Primary completion
- Dec 2002
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of G17DT immunogen in metastatic colorectal cancer (mCRC), sponsored by Cancer Advances, Inc.. Started Mar 2001; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02118064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118064.